FLOMAX demonstrated no clinically meaningful effect on blood pressure2,3,4
- 0.2% incidence of symptomatic postural hypotension reported in 2 US pivotal trials
- Significantly lower incidence of symptomatic postural hypotension than with terazosin or doxazosin-reported in meta-analyses from single-arm, randomized controlled trials5 Learn more about these trials
- FLOMAX is appropriate for both normotensive and hypertensive BPH patients6 See the AUA Treatment Algorithm for pharmacologic management of BPH
- No need to adjust the dosage of these common antihypertensives4
- — atenolol
- — enalapril
- — nifedipine
Trusted safety in the following concomitant conditions
- Patients with moderate hepatic dysfunction
- — No dosage adjustments required
- Patients with moderate renal impairment
- — No dosage adjustments required
- Patients taking certain medications
- — No need to adjust the dosage of digoxin, furosemide or theophylline
 |
Learn more about the proven tolerability of FLOMAX |
Important Safety Information
FLOMAX is indicated to treat the signs and symptoms of benign prostatic hyperplasia (BPH). FLOMAX is not indicated to treat hypertension. As with other alpha-adrenergic blocking agents, there is a potential risk of syncope. Patients beginning treatment with FLOMAX should be cautioned to avoid driving or hazardous tasks for 12 hours after their first dose or increase in dose should syncope occur. The most common side effects are dizziness, abnormal ejaculation, and rhinitis.
Caution should be exercised with concomitant administration of warfarin and FLOMAX. In addition, FLOMAX should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg. FLOMAX is contraindicated in patients known to be hypersensitive to tamsulosin HCl or any component of FLOMAX.
Before prescribing FLOMAX, please see the full Prescribing Information.
